A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma

被引：0
|
作者：
Movva, Sujana
Avutu, Viswatej
Chi, Ping
Dickson, Mark Andrew
Gounder, Mrinal M.
Kelly, Ciara Marie
Keohan, Mary Louise
Meyers, Paul A.
Cohen, Seth M.
Hensley, Martee Leigh
Konner, Jason A.
Schram, Alison M.
Lefkowitz, Robert A.
Erinjeri, Joseph Patrick
Qin, Li-Xuan
Salcito, Tiffany
Seier, Kenneth
Tap, William D.
D'Angelo, Sandra P.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Sarcoma Med Oncol Serv, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11517
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Movva, Sujana
    Avutu, Viswatej
    Chi, Ping
    Dickson, Mark Andrew
    Gounder, Mrinal M.
    Kelly, Ciara Marie
    Keohan, Mary Louise
    Nacev, Benjamin Alexander
    Rosenbaum, Evan
    Thornton, Katherine Anne
    Cohen, Seth M.
    Hensley, Martee Leigh
    Konner, Jason A.
    Schram, Alison M.
    Qin, Li-Xuan
    Lefkowitz, Robert A.
    Erinjeri, Joseph Patrick
    D'Angelo, Sandra P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
    Makker, Vicky
    Taylor, Matthew H.
    Aghajanian, Carol
    Oaknin, Ana
    Mier, James
    Cohn, Allen L.
    Romeo, Margarita
    Bratos, Raquel
    Brose, Marcia S.
    DiSimone, Christopher
    Messing, Mark
    Stepan, Daniel E.
    Dutcus, Corina E.
    Wu, Jane
    Schmidt, Emmett V.
    Orlowski, Robert
    Sachdev, Pallavi
    Shumaker, Robert
    Casado Herraez, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 2981 - 2992
  • [3] A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors
    Kitano, Shigehisa
    Fujiwara, Yutaka
    Shimizu, Toshio
    Iwasa, Satoru
    Yonemori, Kan
    Kondo, Shunsuke
    Shimomura, Akihiko
    Koyama, Takafumi
    Ebata, Takahiro
    Ikezawa, Hiroki
    Hayata, Nozomi
    Minoshima, Yukinori
    Miura, Takuma
    Kubota, Tomoki
    Yamamoto, Noboru
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (06) : 523 - 529
  • [4] A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors
    Shigehisa Kitano
    Yutaka Fujiwara
    Toshio Shimizu
    Satoru Iwasa
    Kan Yonemori
    Shunsuke Kondo
    Akihiko Shimomura
    Takafumi Koyama
    Takahiro Ebata
    Hiroki Ikezawa
    Nozomi Hayata
    Yukinori Minoshima
    Takuma Miura
    Tomoki Kubota
    Noboru Yamamoto
    [J]. Cancer Chemotherapy and Pharmacology, 2022, 90 : 523 - 529
  • [5] Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
    Hunt, Jonathan T.
    Chambers, Laura M.
    Yao, Meng
    Joehlin-Price, Amy
    Debernardo, Robert
    Rose, Peter G.
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [6] PHASE 3 STUDY OF PEMBROLIZUMAB plus BELZUTIFAN plus LENVATINIB OR PEMBROLIZUMAB/QUAVONLIMAB plus LENVATINIB VERSUS PEMBROLIZUMAB plus LENVATINIB AS FIRST-LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMA
    Choueiri, Toni
    Plimack, Elizabeth
    Powles, Thomas
    Voss, Martin
    Gurney, Howard
    Silverman, Rachel
    Perini, Rodolfo
    Rodriguez-Lopez, Karla
    Rini, Brian
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A447 - A447
  • [7] Phase 3 study of first-line treatment with pembrolizumab plus belzutifan plus lenvatinib or pembrolizumab/quavonlimab plus lenvatinib versus pembrolizumab plus lenvatinib for advanced renal cell carcinoma (RCC).
    Choueiri, Toni K.
    Plimack, Elizabeth R.
    Powles, Thomas
    Voss, Martin H.
    Gurney, Howard
    Silverman, Rachel Kloss
    Perini, Rodolfo F.
    Rodriguez-Lopez, Karla
    Rini, Brian I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [8] Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer
    Van Le, Linda
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (05) : 275 - 276
  • [9] Lenvatinib plus Pembrolizumab in advanced Endometrial Carcinoma
    Lorenz, Judith
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (05) : 464 - 464
  • [10] Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
    Makker, V
    Colombo, N.
    Casado Herraez, A.
    Santin, A. D.
    Colomba, E.
    Miller, D. S.
    Fujiwara, K.
    Pignata, S.
    Baron-Hay, S.
    Ray-Coquard, I
    Shapira-Frommer, R.
    Ushijima, K.
    Sakata, J.
    Yonemori, K.
    Kim, Y. M.
    Guerra, E. M.
    Sanli, U. A.
    McCormack, M. M.
    Smith, A. D.
    Keefe, S.
    Bird, S.
    Dutta, L.
    Orlowski, R. J.
    Lorusso, D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05): : 437 - 448
12345